MoneyWorks4Me

Ishita Drugs & Inds. - Quaterly Results

09 Aug 2026 Evaluate
The sales slipped to Rs. 31.45 millions, down -41.76% for the June 2026 quarter as against Rs. 54.00 millions during the year-ago period.The Company's Net profit for the June 2026 quarter have declined marginally to Rs. 2.30  millions as against Rs. 3.03 millions reported during the corresponding quarter ended.The Operating Profit of the company witnessed a decrease to 3.55 millions from 4.39 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202606 202506 % Var 202606 202506 % Var 202603 202503 % Var
Sales 31.45 54.00 -41.76 31.45 54.00 -41.76 146.60 149.97 -2.25
Other Income 0.36 0.91 -60.44 0.36 0.91 -60.44 4.73 3.36 40.77
PBIDT 3.55 4.39 -19.13 3.55 4.39 -19.13 12.38 13.38 -7.47
Interest 0.05 0.23 -78.26 0.05 0.23 -78.26 0.59 0.72 -18.06
PBDT 3.50 4.16 -15.87 3.50 4.16 -15.87 11.79 12.66 -6.87
Depreciation 0.50 0.28 78.57 0.50 0.28 78.57 1.00 1.10 -9.09
PBT 3.00 3.88 -22.68 3.00 3.88 -22.68 10.79 11.56 -6.66
TAX 0.70 0.85 -17.65 0.70 0.85 -17.65 3.02 2.87 5.23
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.01 -0.08 -112.50
PAT 2.30 3.03 -24.09 2.30 3.03 -24.09 7.77 8.69 -10.59
Equity 29.90 29.90 0.00 29.90 29.90 0.00 29.90 29.90 0.00
PBIDTM(%) 11.29 8.13 38.85 11.29 8.13 38.85 8.44 8.92 -5.35
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..